Add Company
Join Now

SimulStat Incorporated Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • SimulStat Incorporated's estimated annual revenue is currently $9.4M per year.(i)
  • SimulStat Incorporated's estimated revenue per employee is $201,000

Employee Data

  • SimulStat Incorporated has 47 Employees.(i)
  • SimulStat Incorporated grew their employee count by 4% last year.

SimulStat Incorporated's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
Senior Director Business DevelopmentReveal Email/Phone
3
Senior Director, Client Success and Business OperationsReveal Email/Phone
4
Manager Business OperationsReveal Email/Phone
5
Business Development ManagerReveal Email/Phone
6
Senior RecruiterReveal Email/Phone
7
Administrative AssistantReveal Email/Phone
8
Senior RecruiterReveal Email/Phone
9
Senior RecruiterReveal Email/Phone
10
Senior RecruiterReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$102.7M51125%N/AN/A
#2
$0.4M20%N/AN/A
#3
$38.6M1923%N/AN/A
#4
$35M1272%$62.5MN/A
#5
$36.6M18218%N/AN/A
#6
$131.9M656-3%N/AN/A
#7
$133.5M664N/AN/AN/A
#8
$72.8M362-4%N/AN/A
#9
$551.9M1716-2%N/AN/A
#10
$11.7M5812%N/AN/A
Add Company

What Is SimulStat Incorporated?

SimulStat provides statistical programming and biostatistics services to the pharmaceutical and biotechnology industry. Whether you need a SAS programmer, a biostatistician or an entire team, working on-site or off-site, we can provide you with the resources that you need. We also provide off-site biostatistics and statistical programming project based solutions for situations when you have a project that your infrastructure cannot support.

keywords:N/A

N/A

Total Funding

47

Number of Employees

$9.4M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.4M49-47%N/A
#2
$3.5M50-2%N/A
#3
$35M520%N/A
#4
$13.1M540%N/A
#5
$8.5M578%N/A